stockportfolio.pro
Stocks / NHC vs RLAY
NHC vs RLAY
National HealthCare Corporation and Relay Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| National HealthCare Corporation (NHC) | Relay Therapeutics, Inc. (RLAY) | |
|---|---|---|
| Market cap | $3.0B | $3.1B |
| Revenue (latest FY) | $1.52B | $15.36M |
| Net income (latest FY) | $120.02M | $-276.48M |
| Revenue growth (5y CAGR) | 8.1% | -28.6% |
| Net margin | 7.9% | -1800.6% |
| Return on equity | 11.2% | -48.8% |
| P/E ratio | 24.5 | — |
| Dividend yield | 1.4% | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open NHC — free Open RLAY — freeFrequently asked questions
Which is bigger, NHC or RLAY?
Relay Therapeutics, Inc. is larger by market capitalization — $3.1B versus $3.0B.
Which grows faster, NHC or RLAY?
Over the last five fiscal years, National HealthCare Corporation grew revenue faster — 8.1%/yr versus -28.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.